• 

  Biocompatible copolymer formulations to treat glioblastoma multiforme. 

  Gobbo, Oliviero (2021)

  The treatment for glioblastoma multiforme (GBM) has not changed for more than 20 years while the prognosis for the patients is still poor and most of them survive less than 1 year after diagnosis. The standard of care for ...
• 

  Medication Safety in Polypharmacy 

  Grimes, Tamasine (World Health Organisation, 2019)

  Ensuring medication safety in polypharmacy is one of the key challenges for medication safety today. Due to the traditional focus of both medical research and health care delivery models on single-disease interventions, ...
• 

  Medication Safety in High-Risk Situations 

  Grimes, Tamasine (World Health Organisation, 2019)

  Each country participating in the third WHO Global Patient Safety Challenge: Medication Without Harm is urged to take early priority action to improve medication safety in high-risk situations and reduce harm by (5): ...
• 

  Extracellular vesicles in blood: are they viable as diagnostic and predictive tools in breast cancer? 

  O'Driscoll, Lorraine (2020)

  Extracellular vesicles (EVs), often described as mini-maps of their cells of origin, are found in the bloodstream and can be rich sources of cargo released from cancer cells. As such, they could be collected through minimally ...
• 

  Extracellular vesicles report on the MET status of their cells of origin regardless of the method used for their isolation. 

  Moran, Barry; O'Driscoll, Lorraine (2020)

  MET pathway is an important actionable target across many solid tumour types and several MET inhibitors have been developed. Extracellular vesicles (EVs) are proposed to be mini-maps of their cells of origin. However, the ...

View more